top of page
Description of service
Intravacc has several detoxified LPS variants available for testing with your antigen of choice. The LPS adjuvant platform technology of Intravacc is open for new collaborations, which can range from out-licensing to large collaborative development, process optimization and cGMP production.
Timeline
Earliest start date October 2017.
Formulation of antigens in LPS adjuvants
Free
Services do NOT include
Animal immunisation experiments.
Sample Requirements - input of users
Antigens of sufficient purity to make addition of LPS adjuvants meaningful.
Lead Scientist
Dr. Peter van der Ley
Publications
bottom of page